Medscape Medical News talked with researcher Stacie Dusetzina about the prospects for a single-payer program to help with the ...

Somite, an AI-native TechBio company building the first universal virtual cell-signaling model, today announced its new identity, Cellular Intelligence. This rebrand reflects the company's vision to ...

True patient-centricity will drive commercial success as CGT moves beyond first-generation therapies. Current timelines in CGT, from diagnosis to treatment, can exceed six months, often compounded by ...

Using human stem cells, scientists have created a miniature lung that mimics breathing and TB infection, opening new ...

Formerly Somite AI, the rebranded company aims to broaden the regenerative medicine landscape by building AI models that ...

Researchers at the Francis Crick Institute and AlveoliX have developed the first human 'lung-on-chip' model using stem cells ...

A study led by Maria Carmo-Fonseca at GIMM has helped clarify one of the main limitations of lab-grown heart cells, which are ...

For the first time, a breathing lung model has been made using cells from only one person. Announced on January 1, the ...

Expected rapid advances in CAR T and other cellular therapies may expand treatment options not only in cancer but also in ...

Randomness inside cells can decide whether a cancer returns after chemotherapy or whether an infection survives antibiotics.

One of the most well-studied cellular responses is how they react during times of stress, such as when the temperature gets ...

PEGASUS generates permeable macrocyclic peptides, offering new promise for a modality that can combine the properties of a biologic in a pill ...